Linklaters acted for OmnigenicsAI Corp (Bioceres Group Plc), Greenberg Traurig advised APx Acquisition Corp. I. APx Acquisition Corp. I (NASDAQ: APXI), a publicly traded special purpose...
OmnigenicsAI Corp (Bioceres Group Plc)’s Business Combination Agreement With APx Acquisition Corp. I
APx Acquisition Corp. I’s $172.5 Million Initial Public Offering
Davis Polk advised APx Acquisition Corp. I on the IPO, while Shearman & Sterling advised the underwriters. APx Acquisition Corp. I executed its $172.5 million initial public...